Delving into the Latest Updates on Beijing Zehui Chenxing Biotechnology Co., Ltd. with Synapse

Overview

Tags

Immune System Diseases

Respiratory Diseases

Skin and Musculoskeletal Diseases

Stem cell therapy

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Immune System Diseases	1

Top 5 Drug Type	Count

Stem cell therapy	1

Primary objective To evaluate the preliminary efficacy of CAStem cell injection in the treatment of acute graft-versus-host disease. Secondary objective To evaluate the safety of CAStem cell injection in the treatment of acute graft-versus-host disease. Exploratory objective To explore the potential relationship between changes in peripheral blood biomarker concentrations before and after CAStem cell injection and efficacy.

Start Date18 Jan 2024

Sponsor / Collaborator

Beijing Zehui Chenxing Biotechnology Co., Ltd.

CTR20231881

/ RecruitingPhase 2

CAStem细胞注射液治疗间质性肺疾病急性加重

[Translation] CAStem cell injection for the treatment of acute exacerbation of interstitial lung disease

主要目的：评价CAStem细胞注射液治疗AE-ILD的初步有效性。次要目的：评价CAStem细胞注射液治疗AE-ILD的安全性。探索性目的：探索CAStem细胞注射液治疗前后外周血生物标志物浓度变化与疗效的潜在关系。

[Translation]

Primary purpose: To evaluate the preliminary effectiveness of CAStem cell injection in the treatment of AE-ILD. Secondary purpose: To evaluate the safety of CAStem cell injection in the treatment of AE-ILD. Exploratory purpose: To explore the potential relationship between the changes in peripheral blood biomarker concentrations before and after CAStem cell injection and the efficacy.

Start Date21 Sep 2023

Sponsor / Collaborator

Beijing Zehui Chenxing Biotechnology Co., Ltd.

CTR20221454

/ RecruitingPhase 2

CAStem细胞注射液治疗急性呼吸窘迫综合征的有效性和安全性研究

[Translation] Study on the efficacy and safety of CAStem cell injection in the treatment of acute respiratory distress syndrome

主要目的：评价CAStem细胞注射液治疗急性呼吸窘迫综合征（ARDS）的初步有效性。次要目的：评价CAStem细胞注射液治疗ARDS的安全性和耐受性。探索性目的：探索CAStem细胞注射液治疗前后外周血和肺泡灌洗液生物标志物变化以及与疗效之间的潜在关系。

[Translation]

Primary objective: To evaluate the preliminary efficacy of CAStem cell injection in the treatment of acute respiratory distress syndrome (ARDS). Secondary objective: To evaluate the safety and tolerability of CAStem cell injection in the treatment of ARDS. Exploratory objective: To explore the changes in biomarkers in peripheral blood and bronchoalveolar lavage fluid before and after CAStem cell injection treatment and their potential relationship with efficacy.

Start Date10 Dec 2022

Sponsor / Collaborator

Beijing Zehui Chenxing Biotechnology Co., Ltd.

100 Clinical Results associated with Beijing Zehui Chenxing Biotechnology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Zehui Chenxing Biotechnology Co., Ltd.

Login to view more data

100 Deals associated with Beijing Zehui Chenxing Biotechnology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Zehui Chenxing Biotechnology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Other

Login to view more data